Van Hulzen Asset Management LLC Makes New Investment in Danaher Corporation $DHR

Van Hulzen Asset Management LLC purchased a new position in shares of Danaher Corporation (NYSE:DHRFree Report) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 116,555 shares of the conglomerate’s stock, valued at approximately $22,201,000. Danaher makes up 1.6% of Van Hulzen Asset Management LLC’s holdings, making the stock its 18th largest position.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. Main Street Group LTD purchased a new position in Danaher during the 1st quarter valued at about $25,000. N.E.W. Advisory Services LLC purchased a new stake in Danaher during the second quarter worth about $25,000. JPL Wealth Management LLC acquired a new stake in shares of Danaher during the third quarter worth about $25,000. WFA of San Diego LLC acquired a new stake in shares of Danaher during the second quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in shares of Danaher in the fourth quarter valued at approximately $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 1.7%

Shares of NYSE DHR opened at $215.18 on Tuesday. The business has a 50-day moving average of $196.49 and a two-hundred day moving average of $192.39. The company has a market capitalization of $151.27 billion, a price-to-earnings ratio of 38.22, a price-to-earnings-growth ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the prior year, the business posted $0.77 EPS. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. On average, analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of research reports. DZ Bank assumed coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. Guggenheim decreased their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. HSBC dropped their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. TD Cowen reduced their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Finally, Piper Sandler started coverage on Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price for the company. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average target price of $228.91.

Read Our Latest Stock Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.